These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15794910)

  • 1. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
    Xu Y; He Z; King GL
    Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
    Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
    J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular and molecular mechanisms of diabetic complications.
    King GL; Brownlee M
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy and atherosclerosis: is there a link?
    Ellis TP; Choudhury RH; Kaul K; Chopra M; Kohner EM; Tarr JM; Chibber R
    Curr Diabetes Rev; 2013 Mar; 9(2):146-60. PubMed ID: 23094754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.
    Madonna R; De Caterina R
    Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The missing link: a single unifying mechanism for diabetic complications.
    Nishikawa T; Edelstein D; Brownlee M
    Kidney Int Suppl; 2000 Sep; 77():S26-30. PubMed ID: 10997687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of diabetic macroangiopathy].
    Nishio Y
    Nihon Rinsho; 2006 Nov; 64(11):1991-7. PubMed ID: 17087288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry and molecular cell biology of diabetic complications.
    Brownlee M
    Nature; 2001 Dec; 414(6865):813-20. PubMed ID: 11742414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
    Fiorentino TV; Prioletta A; Zuo P; Folli F
    Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
    Sheetz MJ; King GL
    JAMA; 2002 Nov; 288(20):2579-88. PubMed ID: 12444865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of hyperglycemia in the development of diabetic microangiopathy].
    Miyata S; Kasuga M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():45-51. PubMed ID: 15999684
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction in type 1 diabetes].
    Bertoluci MC; Cé GV; da Silva AM; Puñales MK
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):416-26. PubMed ID: 18438553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors.
    Hayden JM; Reaven PD
    Curr Opin Lipidol; 2000 Oct; 11(5):519-28. PubMed ID: 11048895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
    Katakami N
    J Atheroscler Thromb; 2018 Jan; 25(1):27-39. PubMed ID: 28966336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical mechanisms in the pathogeny of diabetic retinopathy].
    Zamfir C
    Oftalmologia; 2009; 53(2):8-12. PubMed ID: 19697833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.
    Lee J; Yun JS; Ko SH
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.